Dr. Suzanne Lentzsch is Professor of Medicine and Director of the Multiple Myeloma and Amyloidosis Service at Columbia University. For over two decades, her clinical and translational research has focused on developing novel, patient-centered therapies for plasma cell disorders, particularly multiple myeloma and AL amyloidosis. Dr. Lentzsch’s groundbreaking work led to the first-in-human trial of … Continued
Dr. Chandramouli is a Senior Consultant Haematologist at the Department of Haematology at Singapore General Hospital and National Cancer Center Singapore and the current Head of the SingHealth Duke NUS Blood Cancer Centre. He serves as the sub-Specialty Lead for Multiple Myeloma and Lymphoma in SGH and SingHealth-Duke NUS Blood Cancer Center. He has a … Continued
Dr. Schütz is the Chief of the Hematology Department at Hospital Italiano de Buenos Aires, Argentina, and leads the Hematology Training Program at its affiliated medical school. A clinician and clinical investigator specializing in Multiple Myeloma and its precursor conditions, Dr. Schütz earned her medical degree from Universidad Favaloro and completed postgraduate training in Internal … Continued
Katja Weisel, MD, is associate professor Deputy Head the Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg Germany as well as Co-Director of the German Cancer Aid designated University Cancer Center Hamburg (UCCH). Prof Weisel received her medical degree from the Medical School of the University … Continued
Dr. Usmani received his medical education at Allama Iqbal Medical College in Lahore, Pakistan. He completed a residency in internal medicine at Sinai-Grace Hospital/Wayne State University in Detroit, Michigan and a fellowship in hematology and oncology at the University of Connecticut Health Center in Farmington, Connecticut. He joined the Myeloma Institute for Research & Therapy, … Continued
Elena Zamagni MD, PhD, is an Associate Professor of Hematology at the Bologna University, Italy since January 2021. She received her medical degree from University of Bologna, where she also served her residency in haematology. She got PHD in Clinical Hematology at the University of Bologna in May 2005. She qualified for the position of … Continued
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
